CHOLANGIOCARCINOMA - CURRENT TREATMENT OPTIONS

被引：85
作者：
Friman, S. [1 ]
机构：
[1] Sahlgrens Univ Hosp, Transplant Inst, S-41345 Gothenburg, Sweden
来源：
SCANDINAVIAN JOURNAL OF SURGERY | 2011年 / 100卷 / 01期
关键词：
CA; 19-9; cholangiocarcinoma; liver transplantation; liver resection; primary sclerosing cholangitis; tumour marker; PRIMARY SCLEROSING CHOLANGITIS; LIVER-TRANSPLANTATION; INTRAHEPATIC CHOLANGIOCARCINOMA; HEPATOBILIARY MALIGNANCY; HILAR CHOLANGIOCARCINOMA; SERUM CA-19-9; HEPATITIS-C; CARCINOMA; EXPERIENCE; SURVIVAL;
D O I：
10.1177/145749691110000106
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：30 / 34
页数：5
相关论文
共 33 条
[1]   Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial [J].
Bengala, C. ;
Bertolini, F. ;
Malavasi, N. ;
Boni, C. ;
Aitini, E. ;
Dealis, C. ;
Zironi, S. ;
Depenni, R. ;
Fontana, A. ;
Del Giovane, C. ;
Luppi, G. ;
Conte, P. .
BRITISH JOURNAL OF CANCER, 2010, 102 (01) :68-72
[2]  
BISMUTH H, 1975, SURG GYNECOL OBSTET, V140, P170
[3]   CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis [J].
Björnsson, E ;
Kilander, A ;
Olsson, R .
LIVER, 1999, 19 (06) :501-508
[4]   Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis [J].
Boberg, Kirsten Muri ;
Jebsen, Peter ;
Clausen, Ole Petter ;
Foss, Aksel ;
Aabakken, Lars ;
Schrumpf, Erik .
JOURNAL OF HEPATOLOGY, 2006, 45 (04) :568-574
[5]   Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy [J].
Brandsæter, B ;
Isoniemi, H ;
Broomé, U ;
Olausson, M ;
Bäckman, L ;
Hansen, B ;
Schrumpf, E ;
Oksanen, A ;
Ericzon, BG ;
Höckerstedt, K ;
Mäkisalo, H ;
Kirkegaard, P ;
Friman, S ;
Bjorol, K .
JOURNAL OF HEPATOLOGY, 2004, 40 (05) :815-822
[6]   Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis [J].
Broome, U ;
Olsson, R ;
Loof, L ;
Bodemar, G ;
Hultcrantz, R ;
Danielsson, A ;
Prytz, H ;
SandbergGertzen, H ;
Wallerstedt, S ;
Lindberg, G .
GUT, 1996, 38 (04) :610-615
[7]   Risk factors for biliary tract carcinogenesis [J].
Chapman, RW .
ANNALS OF ONCOLOGY, 1999, 10 :308-311
[8]   Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma [J].
De Vreede, I ;
Steers, JL ;
Burch, PA ;
Rosen, CB ;
Gunderson, LL ;
Haddock, MG ;
Burgart, L ;
Gores, GJ .
LIVER TRANSPLANTATION, 2000, 6 (03) :309-316
[9]  
FLANIGAN DP, 1977, CANCER-AM CANCER SOC, V40, P880, DOI 10.1002/1097-0142(197708)40:2<880::AID-CNCR2820400242>3.0.CO
[10]  
2-X
1234